Accent Therapeutics IPO

Accent Therapeutics is a biopharmaceutical company working to design efficient cancer treatments by looking at small molecule precision therapies. Looking beyond traditional therapies that focus on mutation-specific vulnerabilities, the team is striving to find and target intracellular dependencies for multiple types of cancer using RNA-modifying protein (RMP) biology. Accent Therapeutics was founded in 2017 by Robert A. Copeland, Ph. D., and headquartered in Lexington, MA.

Register for Details

For more details on financing and valuation for Accent Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Accent Therapeutics

Forge green plus iconForge green minus icon

What is Accent Therapeutics's IPO price?

The IPO price for Accent Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Accent Therapeutics?

Accent Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Accent Therapeutics shares pre-IPO?

If you own Accent Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Accent Therapeutics a publicly traded company?

Accent Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

When was Accent Therapeutics founded?

Accent Therapeutics was founded in 2017.

Who are Accent Therapeutics's major investors?

Atlas Venture
Bristol Myers Squibb
EcoR1 Capital
Mirae Asset Capital
The Column Group
Johnson & Johnson Innovation
Paratus Investment
AbbVie Ventures
Timefolio Capital
The Mark Foundation for Cancer Research
Droia Ventures
Updated on: Jun 15, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.